Extracellular vesicles in chronic kidney disease: diagnostic and therapeutic roles

Yixuan Zheng1, Hui Wang1, Xueying Li2

  • 1Chengdu University of Traditional Chinese Medicine, Chengdu, China.

PubMed

Insights

Extracellular vesicles (EVs) play key roles in chronic kidney disease (CKD) progression and outcomes. This review summarizes EV involvement in CKD pathogenesis and their potential as diagnostic biomarkers and therapeutic agents.

Area of Science:

  • Nephrology
  • Biomedical Sciences
  • Cell Biology

Background:

  • Chronic kidney disease (CKD) is a global health issue with high mortality.
  • Extracellular vesicles (EVs) are crucial mediators in kidney disease pathogenesis.
  • EVs influence key renal injury pathways like inflammation, fibrosis, apoptosis, and oxidative stress.

Purpose of the Study:

  • To comprehensively summarize the role of EVs in the physiological and pathological aspects of CKD.
  • To explore the potential of EVs as diagnostic biomarkers for CKD.
  • To review the therapeutic applications of EVs in managing CKD.

Main Methods:

  • Literature review of current research on extracellular vesicles and chronic kidney disease.
  • Analysis of studies investigating EV involvement in renal injury pathways.
  • Synthesis of data on EV-based diagnostic and therapeutic strategies for CKD.

Main Results:

  • EVs are implicated in modulating inflammation, fibrosis, apoptosis, and oxidative stress in CKD.
  • Current research highlights the prevalence of EV applications in CKD diagnosis and treatment.
  • Significant limitations and lack of standardized guidelines exist for EV methodologies.

Conclusions:

  • EVs are integral to CKD pathophysiology and hold promise as biomarkers.
  • Therapeutic applications of EVs in CKD management are under active investigation.
  • Standardization of EV isolation and characterization methods is crucial for clinical translation.